Adenovirus-mediated herpes simplex virus type-1 thymidine kinase gene therapy suppresses oestrogen-induced pituitary prolactinomas

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 3, 2000, Pages 1296-1305

  Windeatt, S ^a   Southgate, T D ^a   Dewey, R A ^a   Bolognani, F ^a   Perone, M J ^a   Larregina, A T ^a   Maleniak, T C ^a   Morris, I D ^a   Goya, R G ^b   Klatzmann, D ^c   Lowenstein P R ^a   Castro, M G ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b INSTITUTO DE INVESTIGACIONES BIOQUÍMICAS DE LA PLATA INIBIOLP   (Argentina)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GANCICLOVIR; SULPIRIDE; THYMIDINE KINASE;

ADENOHYPOPHYSIS; ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL STRAIN GH3; CONTROLLED STUDY; EXPRESSION VECTOR; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS 1; IMMUNOFLUORESCENCE; MALE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; RAT; SUICIDE GENE; TRANSGENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL LINE; ESTROGENS; FLUORESCENT ANTIBODY TECHNIQUE; GENE THERAPY; HERPESVIRUS 1, HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PITUITARY GLAND, ANTERIOR; PITUITARY NEOPLASMS; PROLACTINOMA; RATS; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

ADENOVIRIDAE; ANIMALIA; HERPES; HUMAN HERPESVIRUS 1;

EID: 17744390776     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.3.1296     Document Type: Article

References (34)

1. Asymptomatic hyperprolactinaemia and prolactinoma in the general population - Mass screening by paired assays of serum prolactin
2. Surgical management of pituitary adenomas
3. Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk
4. Dopamine agonists and pituitary tumor shrinkage
5. Prolactinomas and resistance to dopamine agonists
6. Management of prolactinomas
7. Gene therapy strategies for the treatment of pituitary tumours
8. Cell proliferation and death in the irradiated pituitary gland and its modification by growth stimulants
9. Gap junctions play a role in the bystander effect of the herpes virus thymidine kinase ganciclovir system in vitro
10. The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified
11. Expression of transgenes in normal and neoplastic anterior pituitary cells using recombinant adenoviruses: Long term expression, cell cycle dependency, and effects on hormone secretion
12. The basic science of gene therapy
13. Adenoviral-mediated suicide gene therapy using the CNS-1 rat glioma model
14. Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials
15. The use of adenovirus vectors to transfer genes to identified brain cells in vitro
16. Gene transfer into the central and peripheral nervous system using adenoviral vectors
17. Constitutive and enhanced expression from the CMV major IE-promoter in a defective adenovirus vector
18. Cell type specific expression in brain cell cultures from a short human cytomegalovirus major immediate early promoter depends on whether it is expressed from herpesvirus or adenovirus vectors
19. Supernatant rescue assay vs. polymerase chain reaction for detection of wild type adenovirus-contaminating recombinant adenovirus stocks
20. Lipopolysaccharide is a frequent contaminant of plasmid DNA preparations and can be toxic to primary human cells in the presence of adenovirus
21. Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity
22. Quantification of apoptotic events in pure and heterogeneous populations of cells using the flow cytometer
23. Possible interactions between gonadotrophs and somatotrophs in the pituitary of tilapia: Apparent roles for insulin-like growth factor I and estradiol
24. Hypophysectomy
25. Clinical evaluation of a two-site immunoradiometric assay for adrenocorticotrophin in unextracted human plasma using monoclonal antibodies
26. Ganciclovir-induced ablation of non-proliferating thyrocytes expressing herpes virus thymidine kinase occurs by p53-independent apoptosis
27. Liver-associated toxicity of the HSV-TK/GCV approach and adenoviral vectors
28. Effects of estrogen-induced hyperprolactinemia on endocrine and sexual functions in adult male rats
29. A truncated herpes simplex virus thymidine kinase phosphorylates thymidine and nucleoside analogs and does not cause sterility in transgenic mice
30. Transfection of human lactotroph adenoma cells with an adenovirus vector expressing tyrosine hydroxylase decreases prolactin release
31. Targeted expression of toxic genes directed by pituitary hormone promoters: A potential strategy for adenovirus-mediated gene therapy of pituitary tumors
32. Cell-type specific expression in the pituitary: Physiology and gene therapy
33. Characterization of a new animal model of chronic hyperprolactinemia
34. Hypoprolactinoma does not prevent restoration of normal spermatogenesis in gonadotrophin-suppressed, testosterone-replaced rats